Gala Health

What you're buying

Gala is a women's metabolic and hormone service, and its GLP-1 line is narrower than the marketing suggests. What it sells compounded is a GLP-1 and GIP product containing tirzepatide, plus a microdosed version of the same. There is no compounded semaglutide at all — the semaglutide route here is brand-name Ozempic at a cash price, and a Wegovy pill is marked coming soon. Everything is injectable; no oral GLP-1 is available today.

The rest of the account is the reason many people come: estradiol as a pill or a patch, progesterone, vaginal estradiol and non-hormonal options for hot flashes, plus NAD+ and sermorelin on a longevity line. Gala frames the whole thing around midlife — hot flashes, weight gain, brain fog, sleep, low libido — and pairs the GLP-1 with hormone therapy in a way few weight-loss services attempt. The operating company, per the footer, is AI Coaching, Inc.; medical services come from licensed clinicians affiliated with independent practices "including OpenLoop-affiliated medical groups." Gala provides administration and technology and says outright that it does not provide medical care.

What it costs (and how it's billed)

The hero says "$179/mo all doses, no hidden fees." The treatment cards repeat it — compounded GLP-1 and GIP at $179/month, the microdose at $149 a month — and then a single asterisk under all four cards carries the term: "Compounded GLP-1 is not FDA-approved and is sourced from licensed compounding pharmacies. Price calculated based on a yearly subscription plan."

So the headline is an annual rate. There is no month-to-month price published anywhere on this site, and the yearly qualifier is now a footnote rather than a line under the hero, which makes it easier to miss than it was. The FAQ then quotes a third figure that matches neither card: "you can access GLP-1 weight loss medications (not-FDA approved) starting at just $199 per month (with a 3-month plan). Final pricing is determined at checkout based on your selected plan and medication." Three numbers, three different terms, and the only one you can actually buy by the month is not among them.

Brand-name Ozempic is $1,299/mo, which is what a cash-pay patient pays almost anywhere and is not a realistic route for most. Dose changes are free — the FAQ says a higher dose is available at no additional cost, and switching medications costs nothing either — so the flat-price promise is real once you are inside a plan.

Who can order

All fifty states, stated twice: the hero says "Licensed providers in all 50 states" and the FAQ answers the question directly. Whether you need a video visit depends on you, your state and the medication — the FAQ says consultations may be synchronous or asynchronous, that a video visit, if required, is usually only the first one, and that follow-ups run through chat afterward. No list of the states where a live visit is mandatory is published.

Insurance is not required and not accepted. Gala says it works with "a wide network of pharmacies across all 50 states" and names none of them.

How the intake works

A free online assessment starts everything. A state-licensed provider reviews your health history, weight goals and needs and decides whether treatment is appropriate; if it is, the prescription goes to a network pharmacy and ships to you. Ongoing care is asynchronous messaging with a licensed provider at no extra cost, with side-effect guides and provider-adjusted dosing.

There is a free Gala app. What there is not, anywhere on the site, is a named clinician. A logo row reads "OUR DOCTORS TRAINED AND PRACTICED AT" over a set of institution marks, which tells you where unnamed people studied rather than who they are — and Gala's own reviews page and 50,000-plus success-story count are similarly uncheckable.

What we'd want changed

Publish a monthly rate, or say plainly that there isn't one. Gala is better than most of the field at putting a price on the page before the quiz, and it throws that advantage away by making every published figure conditional on a term the reader has to hunt for. Moving the yearly qualifier off the hero and into a shared footnote under four cards has made this worse rather than better, and the FAQ's $199 per month on a three-month plan contradicts both cards.

Then name something. No pharmacy, no clinician, no state list beyond the bare fifty-state claim, and an operating company called AI Coaching, Inc. that a customer would have no reason to associate with the brand. Every one of those is a sentence Gala's competitors already write.

Bottom line

Gala's real strength is the pairing: compounded tirzepatide and hormone therapy on one account, reviewed by the same provider, aimed squarely at women in midlife. That is worth something no price table captures. But the number on the hero is a yearly subscription, the microdose tier carries the same term, and the FAQ quotes a third price on a third plan — so treat every figure here as a starting point for a checkout conversation rather than a rate. And note the molecule: compounded here means tirzepatide, and semaglutide only comes brand-name at $1,299/mo.